Skip to content

Upstream Bio, Inc. UPB Short-Term Investments

Short-Term Investments at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.79B+10.1%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$76.76M+2.4%
Savara logo
SavaraSVRA
$163.98M+7.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$37.99M-84.3%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$57.01M
Theravance Biopharma logo
Theravance BiopharmaTBPH
$106.57M+426%

Other financials

Income statement

See full
Revenue$1.0M+82.7%
Operating income-$43.6M-36.2%
Net income-$40.6M-48.8%
EPS (diluted)-$0.75-47.1%

Balance sheet

See full
Cash & equivalents$96.7M+35.6%
Total debt$1.1M-34.5%
Total equity$304.0M-31.8%
Total assets$318.1M-30.3%

Cash flow

See full
Operating cash flow-$47.9M-16.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$346.11M-40.9%
Enterprise value$250.5M-51.4%
P/S104.2×-151×

Profitability

See full
Operating margin-5,176.5%+1,764pp
Net margin-4,719%+2,752pp

Returns & leverage

See full
Return on equity-41.8%
Debt / equity0.0×
Current ratio23.1×-24.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Upstream Bio, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Upstream Bio, Inc.'s short-term investments?
Upstream Bio, Inc. (UPB) reported short-term investments of $197.86M in Q1 2026.
How has Upstream Bio, Inc.'s short-term investments changed year-over-year?
Upstream Bio, Inc.'s short-term investments decreased by 45.1% year-over-year, from $360.07M to $197.86M.
What is the long-term trend for Upstream Bio, Inc.'s short-term investments?
Over 2 years (2023 to 2025), Upstream Bio, Inc.'s short-term investments has grown at a 69.0% compound annual growth rate (CAGR), from $83.98M to $239.93M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.